Product NDC: | 0023-3615 |
Proprietary Name: | ZYMAXID |
Non Proprietary Name: | gatifloxacin |
Active Ingredient(s): | 5 mg/mL & nbsp; gatifloxacin |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | SOLUTION/ DROPS |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0023-3615 |
Labeler Name: | Allergan, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022548 |
Marketing Category: | NDA |
Start Marketing Date: | 20100519 |
Package NDC: | 0023-3615-01 |
Package Description: | 1 BOTTLE, DROPPER in 1 CARTON (0023-3615-01) > 1 mL in 1 BOTTLE, DROPPER |
NDC Code | 0023-3615-01 |
Proprietary Name | ZYMAXID |
Package Description | 1 BOTTLE, DROPPER in 1 CARTON (0023-3615-01) > 1 mL in 1 BOTTLE, DROPPER |
Product NDC | 0023-3615 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | gatifloxacin |
Dosage Form Name | SOLUTION/ DROPS |
Route Name | OPHTHALMIC |
Start Marketing Date | 20100519 |
Marketing Category Name | NDA |
Labeler Name | Allergan, Inc. |
Substance Name | GATIFLOXACIN |
Strength Number | 5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |